Published in Circ Cardiovasc Qual Outcomes on May 05, 2009
Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med (2014) 1.27
Improving adherence with medication: a selective literature review based on the example of hypertension treatment. Dtsch Arztebl Int (2014) 1.22
Internet-based interventions to promote mental health help-seeking in elite athletes: an exploratory randomized controlled trial. J Med Internet Res (2012) 1.13
Medication adherence among rural, low-income hypertensive adults: a randomized trial of a multimedia community-based intervention. Am J Health Promot (2011) 0.95
Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial. J Clin Hypertens (Greenwich) (2012) 0.87
Evaluation of effectiveness and cost-effectiveness of a clinical decision support system in managing hypertension in resource constrained primary health care settings: results from a cluster randomized trial. J Am Heart Assoc (2015) 0.84
The role of Decision Support System (DSS) in prevention of cardiovascular disease: a systematic review and meta-analysis. PLoS One (2012) 0.84
Linking clinic and home: a randomized, controlled clinical effectiveness trial of real-time, wireless blood pressure monitoring for older patients with kidney disease and hypertension. Blood Press Monit (2013) 0.80
Higher blood pressure control rate in a real life management program provided by the community health service center in China. BMC Public Health (2014) 0.80
Effectiveness of home blood pressure telemonitoring: a systematic review and meta-analysis of randomised controlled studies. J Hum Hypertens (2017) 0.75
Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis. PLoS Med (2017) 0.75
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
Ethics and privacy issues of a practice-based surveillance system: need for a national-level institutional research ethics board and consent standards. Can Fam Physician (2011) 4.29
Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J (2005) 4.06
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int (2013) 3.42
A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J (2007) 3.32
Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis Rheum (2002) 3.24
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA (2007) 3.12
A multimodal analgesia protocol for total knee arthroplasty. A randomized, controlled study. J Bone Joint Surg Am (2006) 2.73
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64
Association between naproxen use and protection against acute myocardial infarction. Arch Intern Med (2002) 2.45
Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds. Circulation (2011) 2.36
A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ (2007) 2.35
Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Crit Care Med (2013) 2.31
Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry (2008) 2.22
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Can J Cardiol (2005) 2.03
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2007) 2.01
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care (2009) 1.89
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. Eur Heart J (2014) 1.88
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol (2012) 1.86
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol (2013) 1.85
The Canadian STOP-PAIN project - Part 1: Who are the patients on the waitlists of multidisciplinary pain treatment facilities? Can J Anaesth (2010) 1.80
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J (2009) 1.79
Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. J Am Coll Cardiol (2004) 1.72
Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial. J Am Coll Cardiol (2013) 1.70
Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol (2009) 1.68
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Can J Cardiol (2006) 1.67
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. Kidney Int (2012) 1.63
Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension (2006) 1.58
Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care (2010) 1.57
Survey on transfusion practices of pediatric intensivists. Pediatr Crit Care Med (2002) 1.55
Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatment. Can Respir J (2004) 1.55
Genome-wide scan for linkage to obesity-associated hypertension in French Canadians. Hypertension (2005) 1.55
The Canadian STOP-PAIN project - Part 2: What is the cost of pain for patients on waitlists of multidisciplinary pain treatment facilities? Can J Anaesth (2010) 1.54
Emergence of sex differences in prevalence of high systolic blood pressure: analysis of a longitudinal adolescent cohort. Circulation (2006) 1.52
The pharmacokinetics of ezetimibe. Can J Clin Pharmacol (2003) 1.51
Oral anticoagulants and the risk of osteoporotic fractures among elderly. Pharmacoepidemiol Drug Saf (2004) 1.50
The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy. Can J Cardiol (2002) 1.49
Restrictive access to clopidogrel and mortality following coronary stent implantation. CMAJ (2008) 1.46
Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study. J Thorac Cardiovasc Surg (2007) 1.44
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2010) 1.44
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy. Can J Cardiol (2009) 1.42
The medical interview: setting, nonverbal language, and social roles. Can Fam Physician (2004) 1.41
The motivational interview. Can Fam Physician (2007) 1.41
Enlargement of catheter ablation lesions in infant hearts with cryothermal versus radiofrequency energy: an animal study. Circ Arrhythm Electrophysiol (2011) 1.40
Nature and frequency of exchanges on medications during primary care encounters. Patient Educ Couns (2006) 1.40
Willingness to pay to eliminate the risk of restenosis following percutaneous coronary intervention: a contingent valuation. Circ Cardiovasc Qual Outcomes (2010) 1.39
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol (2011) 1.38
Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial. Circulation (2013) 1.32
Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncology. Can J Clin Pharmacol (2009) 1.30
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2008) 1.25
The importance of piloting an RCT intervention. Can J Nurs Res (2009) 1.25
Prevalence of and risk factors for persistent postoperative nonanginal pain after cardiac surgery: a 2-year prospective multicentre study. CMAJ (2014) 1.23
Dosage of enoxaparin among obese and renal impairment patients. Thromb Res (2004) 1.22
Blood pressure variables and cardiovascular risk: new findings from ADVANCE. Hypertension (2009) 1.22
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. JAMA Intern Med (2016) 1.21
Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke (2008) 1.21
Genes, maternal smoking, and the offspring brain and body during adolescence: design of the Saguenay Youth Study. Hum Brain Mapp (2007) 1.19
The ATP-binding cassette transporters and their implication in drug disposition: a special look at the heart. Pharmacol Rev (2006) 1.16
High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology (2003) 1.14
How critical is the duration of the sampling scheme for the determination of half-life, characterization of exposure and assessment of bioequivalence? J Pharm Pharm Sci (2011) 1.14
Patients' experience of chronic illness care in a network of teaching settings. Can Fam Physician (2012) 1.13
Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother (2005) 1.12
Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol (2009) 1.11
Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction. Clin Endocrinol (Oxf) (2009) 1.10
The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition. Pharmacol Rev (2012) 1.10
Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Public Health (2012) 1.09
Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biochem (2002) 1.09
Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation (2003) 1.09
A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study. CMAJ (2010) 1.09
Hyperaldosteronism and hypertension: ethnic differences. Hypertension (2005) 1.05
Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease. Eur J Clin Pharmacol (2005) 1.05
Community pharmacists' interventions in asthma care: a descriptive study. Ann Pharmacother (2008) 1.05
A common variant of the FTO gene is associated with not only increased adiposity but also elevated blood pressure in French Canadians. Circ Cardiovasc Genet (2009) 1.05
ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia. J Clin Endocrinol Metab (2014) 1.05
Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol (2010) 1.04
The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J (2006) 1.04
Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. J Endocrinol (2004) 1.04
Communication tips. Feeling understood: expression of empathy during medical consultations. Can Fam Physician (2007) 1.02
Impact of the socioeconomic status on the probability of receiving formulary restricted thiazolidine (TZDs). Can J Clin Pharmacol (2008) 1.02
Effect of statin adherence on cerebrovascular disease in primary prevention. Am J Med (2009) 1.01
Cell volume and monovalent ion transporters: their role in cell death machinery triggering and progression. Am J Physiol Cell Physiol (2013) 1.01
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. Clin Sci (Lond) (2006) 1.00
Cohort profile of the CARTaGENE study: Quebec's population-based biobank for public health and personalized genomics. Int J Epidemiol (2012) 1.00
Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial. Circ Cardiovasc Imaging (2012) 1.00
Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistance. Health Policy (2003) 1.00
Results of a national survey on over-the-counter medicines, Part 1: Pharmacist opinion on current scheduling status. Can Pharm J (Ott) (2012) 0.99
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia (2014) 0.99
Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice. J Clin Invest (2009) 0.98
Cardiotonic steroids differentially affect intracellular Na+ and [Na+]i/[K+]i-independent signaling in C7-MDCK cells. J Biol Chem (2004) 0.98
Systematic, genome-wide, sex-specific linkage of cardiovascular traits in French Canadians. Hypertension (2008) 0.97
Proteome analysis and functional expression identify mortalin as an antiapoptotic gene induced by elevation of [Na+]i/[K+]i ratio in cultured vascular smooth muscle cells. Circ Res (2002) 0.97
Intercultural communication competence in family medicine: lessons from the field. Patient Educ Couns (2005) 0.95
Results of a national survey on OTC medicines, Part 2: Do pharmacists support switching prescription agents to over-the-counter status? Can Pharm J (Ott) (2012) 0.94
Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother (2013) 0.93
Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab (2004) 0.92
Healthcare professionals' adoption and use of a clinical information system (CIS) in primary care: insights from the Da Vinci study. Int J Med Inform (2011) 0.92